EndoGene.Bio
EF 2022 · Turning menstrual blood into better drugs for endometriosis.
Same space
| Company | Category | Status | Program |
|---|---|---|---|
 Crane BiosciencesShared: biotechnology, healthcare, bloodNot statedOther | Other | Not stated | EF2022 |
 QvinShared: menstrual bloodActiveAI | AI | Active | YCW16 |
 OminiShared: healthcare, bloodNot statedOther | Other | Not stated | EF2019 |
 DeeplifeShared: biotechnology, drugNot statedOther | Other | Not stated | EF2019 |
 Anja HealthShared: healthcare, bloodAcquiredOther | Other | Acquired | YCW22 |
Also from EF
All of EF
Programs
| Program | Cohort | Source |
|---|---|---|
 Entrepreneur First | 2022 | EF Page |
About EndoGene.Bio
- Category
- Other
- Location
- Paris
- Checked
- 3h ago
Tags: Biotechnology, Healthcare
EndoGene.Bio: questions
Which accelerators did EndoGene.Bio go through?
EndoGene.Bio is listed by Entrepreneur First (2022).
Where is EndoGene.Bio based?
EndoGene.Bio lists Paris as its location on Entrepreneur First's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.